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Introduction
Prevention remains the best approach to reduce the bur-
den of stroke despite the availability of thrombolytic
treatment for selected patients and the promise of other
experimental therapies [1, 2]. Identification of the pop-
ulation at risk for vascular events and planning of spe-
cific interventions is therefore of great importance.
Stroke as a public health problem is not so much the
result of individuals with one marked abnormality of a
single risk factor. It is more the result of individuals with
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■ Abstract Background and Pur-
pose Identification of the popula-
tion at risk of stroke remains the
best approach to assess the burden
of cardiovascular morbidity and
mortality. Methods The prevalence
of hypertension (HT), hypercholes-
terolemia (HCh), diabetes mellitus
(DM), overweight (OW), obesity
(OB), tobacco use (SM), and their
combinations was examined in
4458 Swiss persons (1741 men and
2717 women, mean age 57.8 ± 15
years), who volunteered for the
present survey. Results OW was the
most prevalent risk factor (50 %),
followed by HT (47 %), HCh (33 %),
SM (13 %) and DM (1.6 %). The
proportion of persons without risk
factors (RF) was 19.9 %, with 1 RF
41.5 %, 2 RF 33.8 %, 3 RF 4 %, and 4
RF 0.9 %. OW was more prevalent
in men than in women (53 %
vs. 41 %, P = 0.02). More men than
women aged 41–50 years and
51–60 years had HT (49 % vs. 36 %,
P = 0.01, and 52 % vs. 42 %,
P = 0.02). The prevalence of HCh
and DM did not show any sex-re-
lated differences. HT, OW and HCh
were not only the most common
single risk factors, but were also
most likely to aggregate with each
other. Conclusions The majority of
Swiss people have one or two vas-
cular risk factors. OW and HT are
by far most common and are likely
to aggregate with each other. A
small modification of these two
factors would reduce the incidence
of stroke and myocardial infarction
significantly.
■ Key words vascular risk 
factors · stroke · 
epidemiology · hypertension ·
hypercholesterolemia · 
obesity · Switzerland
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minor abnormalities across a number of risk factors [3].
Clusters of multiple risk factors rather than a single fac-
tor determine the cardiovascular risk of the population
[4].
Previous population-based studies have assessed the
prevalence of single vascular risk factors [5–12], while
the prevalence of multiple risk factors has received less
attention [13–16]. Important research has focused on
the metabolic syndrome, a combination of risk factors
leading to insulin resistance and excess risk of cere-
brovascular and cardiovascular disease, while other
combinations have received little attention.
The aim of the present study was to examine the
prevalence of common vascular risk factors and their
combinations in a large cohort of healthy Swiss persons,
using data from the National Stroke Prevention Cam-
paign of the Swiss Heart Foundation and the Swiss Cere-
brovascular Working Group.
Patients and methods
■ Data sources and subjects
The stroke prevention campaign “Meeting Point Heart and Brain”
took place in eight shopping malls in Switzerland from February 2001
to September 2001.It was part of the National Stroke Prevention Cam-
paign 2000/2001 entitled “Stroke – Knowing The Risks, Seizing The
Chances” organized by the Swiss Heart Foundation in collaboration
with the Swiss Cerebrovascular Working Group [17, 18].
Supermarkets and shopping malls in Switzerland serve all social
classes of the community. Therefore, participants in the present study
are very likely to represent all social and ethnic groups within Swiss
society.
Overall 4458 persons (1741 men and 2717 women, mean age
57.8 ± 15 years, range 4 to 95) participated in the study. They under-
went measurements of blood pressure (BP), total cholesterol (TC),
blood glucose, body mass index (BMI) and were asked about their
smoking habits. Measurements were carried out by physicians and
nurses from the neurology and cardiology departments of the near-
est community or university hospital. Participants were informed
about the results and, if necessary, they were advised to modify their
life-style and/or to contact their general practitioner in order to per-
form additional investigations or to start treatment.
■ Measurement of blood pressure/Definition of hypertension (HT)
Persons were seated quietly in a chair, with feet on the floor, and arms
supported at heart level [19]. Blood pressure measurements were per-
formed using a brachial cuff and a standardized sphygmomanometer
according to the method of Riva-Rocchi. Systolic blood pressure
(SBP) was considered the cuff pressure at which the first vascular
sound was heard, and diastolic blood pressure (DBP) was the point
when sounds disappeared during lowering of the cuff pressure. Two
measurements were made in each individual and the mean values of
SBP and DBP were documented.
Hypertension was defined as SBP 140 mm Hg or greater and/or
DBP 90 mm Hg or greater. Persons taking antihypertensive medica-
tion were also considered hypertensive even when their blood pres-
sure readings were normal [20].
■ Measurement of total cholesterol/Definition 
of hypercholesterolemia (HCh)
The total cholesterol (TC) was measured in capillary blood. Hyper-
cholesterolemia (TC values ≥ 6.2 mmol/l) was defined according to
the recommendations of the National Cholesterol Educational Pro-
gram (NCEP) for non-fasting testing conditions [21].Persons with TC
values from 5.2 to 6.2 mmol/l were not considered hypercholes-
terolemic in the present study. They were advised to contact their
family physician in order to perform a fasting lipoprotein profile and
to start an appropriate management, if indicated.
■ Measurements of blood glucose/Definition of diabetes mellitus (DM)
Levels of fasting and non-fasting glucose in blood were measured in
capillary blood. Criteria for the diagnosis of DM were an established
disease of diabetes or casual plasma glucose greater than 11 mmol/l
[22].
■ Measurement of Body Mass Index (BMI)/Definition of overweight (OW)
and obesity (OB)
Body weight was measured in light clothes. The body mass index was
calculated by dividing a person’s weight in kilograms by height in me-
ters squared.According to the definitions of the American Obesity As-
sociation, a BMI between 25.0 to 29.9 was considered overweight and
a BMI of 30 or more obese [23].
■ Definition of current cigarette smoking (SM)
Current smokers were identified by the question “Do you smoke every
day, some days, or not at all?” recommended by the National Center
for Health Statistics for estimate of smoking prevalence [24].
■ Definition of metabolic syndrome (MS)
Subjects with the metabolic syndrome were defined by criteria simi-
lar to those of the Third Report of the National Cholesterol Education
Program’s Adult Treatment Panel (ATP III) [25], i. e. any three of the
following: casual plasma glucose ≥ 11 mmol/l, BMI ≥ 30 kg/m2, blood
total cholesterol ≥ 6.2 mmol/, blood pressure ≥ 140/90 mmHg (or
treated hypertension).
■ Statistical analysis
Descriptive statistics were performed using SPSS 10 for MacIntosh
statistical software©, 2001, SPSS Inc. Age, blood pressure, blood con-
centrations of total cholesterol and glucose are given as mean values,
standard deviations, minimal and maximal values. The prevalence of
individual risk factors and the prevalence of combinations of two or
more risk factors were assessed for the entire population, for persons
younger than 30 years, for persons of every decade between 30 and 80
years and for persons older than 80 years. The two-sided t-test was
used to assess differences between age groups.Values of P < 0.05 were
considered statistically significant.
Results
■ Prevalence of individual risk factors
The age of the study participants is shown in Tables 1 to
5. Age groups < 30 years and > 80 years were relatively
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small (n = 238 and n = 141) but still sufficiently large to
perform a statistical analysis. Overall, 6.1 per 10,000 of
the main resident population of Switzerland26 partici-
pated in the present survey (Table 1). The participation
rate among persons older than 40 years reached about
10 per 10,000 inhabitants.
The prevalence of individual risk factors of different
age groups is summarized in Table 2. Overweight was
the most prevalent vascular risk factor, especially in the
seventh decade of life. Fifty eight percent of the persons
aged 61 to 70 years and 50 % of all participants had a
body mass index of 25–29.9.A BMI ≥ 30, i. e. obesity, was
observed in 11 % of all participants, and among individ-
uals between 61 and 70 years of age in 12.7 %. Hyperten-
sion was the second most prevalent risk factor (47 %). Its
prevalence increased continuously up to the age group
> 80 years (59.3 %). The prevalence of hypercholes-
terolemia showed a similar continuous increase with age
up to 44.8 % in persons older than 80 years. Diabetes
mellitus was diagnosed in 1.6 % of the participants. It
was most common among individuals aged 41–50 years
(2.5 %) and those older than 80 years (3.4 %). Cigarette
smoking was reported by 13 % of the participants. It was
more prevalent in the young (< 30 to 50 years) than
among persons aged 51 years and older. Significant dif-
ferences between age groups are indicated in Table 2.
■ Coincidence of vascular risk factors
The prevalence of persons without a vascular risk fac-
tor, with one and with more than one risk factors is
summarized in Table 3. The proportion of persons with-
out any of the assessed 5 vascular risk factors was 35 %
in the group younger than 30 years and decreased with
advancing age. Only 9.2 % of the participants aged 80
years and older were free of any of the 5 risk factors.
The overall proportion of persons with one risk factor
was 41.5 % and did not differ significantly between the
age groups. The coincidence of 2 risk factors was pres-
ent in 20 % of the participants younger than 30 years.
Above this age, the coincidence of 2 risk factors was ob-
served in up to 41 % of the participants. Three risk fac-
tors in one and the same person were present in 2.8 %
to 4.6 % of all persons. The coincidence of 4 risk factors
was rare, less than 1.1 % in participants younger than 80
years of age.
■ Gender-related differences of individual risk factors
Overweight was more prevalent in men than in women
(53 % vs. 41 %, P = 0.02). This difference was observed in
all age groups except the last one (> 80 years), where
overweight was more frequent among women than
among men (54 % vs. 39 %). Obesity tended also to be
more prevalent in men than women (11 % vs. 10 %), but
this was not statistically significant. Significantly more
men than women aged 41–50 years and 51–60 years had
hypertensive blood pressure values (49 % vs. 36 %,
P = 0.01, and 52 % vs. 42 %, P = 0.02). The prevalence of
hypercholesterolemia and diabetes mellitus did not
show any sex-related differences. Men were smoking
more often than women (18 % vs. 12 %), but the diffe-
Age 0–19 years 20–39 years 40–64 years 65–79 years > 80 years Total
Study participants 40 555 2161 1513 189 4458
Swiss population 1664865 2078962 2394244 824247 299892 7262210
Participation rate 0.24 2.7 9.0 18.4 6.3 6.1
per 10,000 people
Table 1 Participation rate per 10,000 people with
respect to age in the main resident population of
Switzerland (data extrapolated from the bulletin of
the Swiss Federal Statistical Office [26])
Table 2 Prevalence of individual risk factors of different age groups
Age, years Overall
Risk factor
< 30 31–40 41–50 51–60 61–70 71–80 > 80
(n = 238) (n = 425) (n = 631) (n = 985) (n = 1256) (n = 782) (n = 141)
Overweight 28.8% 41.5%a 44.4% 50.0%b 57.5%a 52.7%b 48.9% 50.0%
Obesity 6.8% 8.5% 9.0% 10.5% 12.7% 11.7% 8.5% 10.9%
Hypertension 32.8% 34.8% 40.8% 44.5% 51.0%d 55.8% 59.3% 47.2%
Hypercholesterolemia 24.0% 25.5% 25.9% 34.3%e 38.2% 38.3% 44.8% 33.7%
Diabetes mellitus 0.6% 1.0% 2.5% 0.9%b 1.1% 0.9% 3.4%c 1.6%
Smoking 16.9% 17.0% 17.4% 14.9% 12.3% 8.7%f 12.5% 13.2%
a P = 0.001, difference to the previous decade; b P = 0.02; c P = 0.05; d P = 0.008; e P = 0.003; f P = 0.03
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rence was significant only for the age between 41 and 50
years (P = 0.02).
■ Coincidence of vascular risk factors: 
gender-related differences
More women than men were free of vascular risk factors
(24 % vs. 13 %). Differences were significant in age
groups < 30 years (39 % vs. 20 %, P = 0.02), 31–40 years
(40 % vs. 15 %, P < 0.001), 41–50 years (30 % vs. 15 %,
P = 0.001), 51–60 years (20 % vs. 11 %, P = 0.005). One
vascular risk factor was equally frequent in men and
women up to the age of 80 years. In octogenarians one
vascular risk factor was more prevalent in men than in
women (48 % vs. 12.5 %, P = 0.005). The coincidence of
two, three and four risk factors did not differ in men and
women (30 % vs. 25 %, 4 % vs. 2.6 % and 1.2 % vs. 0.3 %,
P > 0.05).
■ Coincidence of vascular risk factors: 
most prevalent clusters
The coincidence of HT + OW was the most prevalent
combination of vascular risk factors in the cohort
(10.3 %) followed by HT + HCh (6.8 %) and HCh + OW
(5.6 %). HT + OW + SM, and HCh + OW + SM were the
most common triple combinations of risk factors (1.2 %
and 1 %). Clusters of 4 risk factors were rare (0.8 %). If
present, most often SM + HCh + HT + OW were com-
bined (0.6 %). The prevalence of the remaining combi-
nations of 2, 3 and 4 risk factors was less than 2 %, 1 %
and 0.1 % respectively.
Table 4 indicates the frequency of isolated risk factors
and the common combinations in all the age groups.
■ Prevalence of the metabolic syndrome
The metabolic syndrome was present in 0.9 % of all par-
ticipants. It occurred in all age groups and men and
women with a similarly low frequency (Table 5).
Table 3 Prevalence of persons without RF, with 1 RF, and with > 1 RF
Age, years Overall
Number of RF
in an individual < 30 31–40 41–50 51–60 61–70 71–80 > 80
(n = 238) (n = 425) (n = 631) (n = 985) (n = 1256) (n = 782) (n = 141)
No RF 35.0% 30.6% 25.2% 18.6%a 14.4%b 16.6% 9.2% 19.9%
1 RF 40.6% 38.0% 39.2% 44.5% 39.5% 43.3% 44.6% 41.5%
2 RF 20.0% 28.0% 30.2% 31.8% 41.0%b 36.0% 36.9% 33.8%
3 RF 4.3% 2.8% 4.2% 3.9% 4.2% 3.9% 4.6% 4.0%
4 RF 0.0% 0.4% 1.1% 1.1% 0.8% 0.2% 4.6%c 0.9%
RF vascular risk factors
a P = 0.006, difference to the previous age group; b P = 0.02; c P < 0.001
Table 4 Age distribution of the most prevalent risk factors and clusters
Age, years Overall
Single risk factors
and clusters < 30 31–40 41–50 51–60 61–70 71–80 > 80
(n = 238) (n = 425) (n = 631) (n = 985) (n = 1256) (n = 782) (n = 141)
HT (only) 10.6% 10.3% 11.0% 13.7% 11.4% 16.9% 15.6% 13.2%
OW (only) 10.6% 9.9% 11.0% 11.9% 11.9% 8.9% 10.4% 10.8%
HCh (only) 7.9% 8.2% 8.0% 9.7% 5.9% 8.7% 7.8% 7.8%
HT + OW 4.6% 8.9% 10.3% 9.0% 12.0% 11.9% 7.8% 10.3%
HT + HCh 5.3% 5.0% 4.8% 6.5% 8.6% 7.7% 11.7% 6.8%
HCh + OW 5.3% 3.9% 4.5% 5.6% 7.0% 5.4% 6.5% 5.6%
HT + OW + SM 2.0% 0.7% 1.3% 0.6% 1.4% 1.2% 2.6% 1.2%
HCh + OW + SM 0.0% 1.0% 0.5% 1.8% 1.1% 1.0% 1.3% 1.0%
SM + HCh + HT + OW 0.0% 0.4% 1.0% 0.8% 0.6% 0.2% 1.3% 0.6%
HT hypertension; OW overweight; HCh hypercholesterolemia; SM smoking
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Discussion
Hypertension, tobacco use, high cholesterol and over-
weight are well recognized risk factors for stroke and
myocardial infarction. They belong to the 10 major risk
factors for global and regional burden of vascular dis-
ease and account for many million deaths worldwide
each year [27]. Switzerland is among the countries with
low stroke mortality rates. Nevertheless, cardiovascular
disorders including stroke are the leading cause of death
in Switzerland. There were 25,443 cardiovascular deaths
in 1998 and 25,449 such deaths among 62,449 overall
deaths in 1999 (= 40.7 %) [28].
Well-organized and focused prevention has the po-
tential to change the fate of thousands of persons in
Switzerland. In order to target prevention, the preva-
lence of risks has to be known. In this survey, the overall
prevalence of overweight (50 %) was most common, fol-
lowed by hypertension (47 %), hypercholesterolemia
(34 %), smoking (13 %), obesity (11 %) and diabetes
(1.6 %). Only 19.9 % of the participants of the present
study were free of vascular risk factors. In general,young
people and women showed fewer risk factors than men
and older people. This may partly explain why women
live longer than men in the Swiss population. The preva-
lence of risk factors increased with advancing age and
also combinations of risk factors. Clusters of 2 risk fac-
tors were observed in 33.8 %, 3 risk factors in 4 % and 4
in 0.9 % of this cohort. Hypertension, overweight and
hypercholesterolemia were not only the most common
single risk factors, but were also most likely to aggregate
with each other (Table 4).
Persons with single risk factors such as hypertension,
overweight or hypercholesterolemia and persons with
clusters of 2 risk factors should receive special attention
in future preventive programs. Their personal risk is
lower than the risk of the relatively small fraction of
people with more than 2 risk factors. However, an ex-
trapolation of our data to the main resident population
suggests that 4,647,814 persons in Switzerland have one
or two risk factors and the big bulk of cardio- and cere-
brovascular attacks will occur in this large group. A
small modification of their risk will have a big impact.
The metabolic syndrome was very rare in this cohort.
Compared with the San Antonio Heart and Framingham
Offspring studies, the prevalence of the metabolic syn-
drome in our cohort was significantly lower (0.95 %
vs. 24 %) [29]. In part this might be due to a method-
ological difference. However, our study design did not
allow a strict adherence to the ATP III criteria [25]. For
instance, many of the glucose measurements were post-
prandial. Therefore we had to define diabetes by estab-
lished diagnosis and/or casual plasma glucose greater
than 11 mmol/l. It might be that diabetes was under-
diagnosed in our cohort. However, even so, the preva-
lence of the metabolic syndrome in the Swiss population
appears to be rather low. In a mass prevention strategy
such persons are not the main targets, which – of course
– does not mean that they should not receive optimal
preventive and medical care once they are identified.
In addition to the prevalence of risk factors at a given
time the change of risk factors with time is of interest. In
Switzerland, to our knowledge only few data on vascular
risk factors were compiled in previous years. The last
surveys were conducted in three Swiss communities be-
tween 1984 and 1993, within the international research
project MONICA (Monitoring of Trends and Determi-
nants in Cardiovascular Disease [30]).The methodology
of MONICA and our data collection differed consider-
ably. Therefore, a comparison is not feasible. However,
the prevalence of overweight and obesity was signifi-
cantly higher in this than in the Swiss Nutri-Trend-
Study, which was supported by the Swiss Federal Office
of Public Health, and was also conducted in 2000 [30].
The most likely explanation of the latter discrepancy are
differences in the investigated population. The Nutri-
Trend Study was performed in a random sample of 1004
persons aged 18–74 years who were recruited from all
parts of Switzerland.
Recent data from the US Centers for Disease Control
and Prevention indicate that nearly two thirds of Amer-
ican adults are overweight, more than 30 % obese and
nearly 8 % diabetic, and 24 % have the metabolic syn-
drome [31]. Thus, the latter vascular risk factors seem to
be less prevalent in Swiss than in US American Resi-
dents, but also increasing.
Our study has some limitations. It included individu-
als from all groups within Swiss society, who expressed
actively their consent to participate in the examinations.
It might be that individuals with previously diagnosed
vascular risk factors, personal or familial history of car-
diovascular or cerebrovascular diseases were more
Age, years Overall
< 30 31–40 41–50 51–60 61–70 71–80 > 80
(n = 238) (n = 425) (n = 631) (n = 985) (n = 1256) (n = 782) (n = 141)
Overall 0% 0.71% 1.75% 1.12% 0.63% 0.40% 1.9% 0.95%
Men 0% 1.81% 2.41% 1.05% 1.22% 1.16% 3.8% 1.59%
Women 0% 0.00% 0.54% 0.96% 0.32% 0.00% 0.0% 0.26%
Table 5 Prevalence of the metabolic
syndrome
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likely to participate. Therefore, inclusion bias cannot be
ignored. Self-selection might also explain the predomi-
nance of female participants in our study (61 %). Sec-
ond, in some individuals the measurements were per-
formed postprandially, which prevented the prevalence
of DM to be assessed correctly. Third, data concerning
patients’ history and treatments were not based on med-
ical records.Therefore, they might have been incomplete
in some cases.
In conclusion, the majority of Swiss people have one
or two vascular risk factors. Overweight and hyperten-
sion are by far most common and are likely to aggregate
with each other. A small modification of these two fac-
tors would reduce the incidence of stroke and myocar-
dial infarction significantly.
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